RAAPID INC CEO Discusses Market Position with CB Insights
RAAPID INC CEO Chetan Parikh spoke with CB Insights about the company's role in the risk adjustment market, linking clinical documentation to payment. The market is valued at $3 billion and projected to grow.
Chetan Parikh, CEO of RAAPID INC, has detailed his company's operations and market positioning in an interview with CB Insights. RAAPID INC operates in the risk adjustment sector, an area where clinical documentation directly translates into payment for healthcare providers.
This process is critical for Medicare Advantage plans, Affordable Care Act (ACA) plans, and any provider taking on financial risk. These entities rely on accurately capturing and defending the health status of their patients to ensure appropriate reimbursement.
The risk adjustment market is currently valued at approximately $3 billion, with projections indicating a rise to $9 billion by 2033, according to Parikh. However, he highlighted that the true scale of the market lies in the payments made by Medicare Advantage for its 35 million members, a figure exceeding half a trillion dollars.
Parikh emphasized that RAAPID INC's technology is designed to significantly impact these substantial financial flows within the healthcare system. The interview provided an overview of the company's business focus without detailing specific upcoming initiatives.